Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane

Strahlentherapie und Onkologie

Volumn 187, Issue 9, 2011, Pages 575-580

  Kotowski, Ulana ^a   Heiduschka, Gregor ^a   Brunner, Markus ^a   Czembirek, Cornelia ^a   Eder Czembirek, Christina ^a   Schmidt, Rainer ^a   Fahim, Tammer ^a   Thurnher, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Head and neck cancer; Radiation; Radiosensitizer; Sulforaphane

Indexed keywords

PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; PROTEIN MCL 1; SULFORAPHANE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CLONOGENIC ASSAY; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; PHYTOTHERAPY; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION-SENSITIZING AGENTS; THIOCYANATES; TUMOR STEM CELL ASSAY;

EID: 80755172187     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2218-6     Document Type: Article

References (28)

1. Basten G P, Bao Y, Williamson G. Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UG-T1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis 2002;23:1399-404.
2. Berger B, Belka C, Weinmann M et al. Reirradiation with alternating docetaxelbased chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlenther Onkol 2010;186:255-61.
3. Bieri S, Bentzen SM, Huguenin P et al. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. Strahlenther Onkol 2003;179:390-5. (Pubitemid 36693263)
4. Brooks JD, Paton VG, Vidanes G. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev 2001;10:949-54. (Pubitemid 32844902)
5. Cho N P, Han HS, Leem DH et al. Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model. Oral Oncol 2009;45:654-60.
6. Choi WY, Choi BT, Lee WH et al. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother 2008;62:637-44.
7. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58:621-81.
8. Eder-Czembirek C, Erovic BM, Czembirek C et al. Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 2010;186:143-8.
9. Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Mutat Res 2007;635:90-104. (Pubitemid 46756397)
10. Gamet-Payrastre L, Li P, Lumeau S et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000;60:1426-33. (Pubitemid 30152017)
11. Heiduschka G, Erovic BM, Vormittag L et al. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2009;135:261-7.
12. Higdon JV, Delage B, Williams DE et al. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 2007;55:224-36. (Pubitemid 46518152)
13. Jackson SJ, Singletary KW. Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 2004;25:219-27. (Pubitemid 38239805)
14. Maheo K, Morel F, Langouet S et al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 1997;57:3649-52. (Pubitemid 27381200)
15. Myzak MC, Dashwood RH. Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Lett 2006;233:208-18. (Pubitemid 43327375)
16. Myzak MC, Hardin K, Wang R et al. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006;27:811-9.
17. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
18. Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007;6:1013-21. (Pubitemid 46554571)
19. Riedl MA, Saxon A, Diaz-Sanchez D. Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin Immunol 2009;130:244-51.
20. Singh AV, Xiao D, Lew KL et al. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004;25:83-90. (Pubitemid 38128621)
21. Steinmann D, Cerny B, Karstens JH et al. Chemoradiotherapy with weekly cisplatin 40 mg/m (2) in 103 head-and-neck cancer patients: a cumulative doseeffect analysis. Strahlenther Onkol 2009;185:682-8.
22. Tribius S, Kronemann S, Kilic Y et al. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009;185:675-81.
23. Whisler LC, Wood NB, Caldarelli DD et al. Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope 1998;108:630-8. (Pubitemid 28213479)
24. Wiltfang J, Grabenbauer G, Bloch-Birkholz A et al. [Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study-first results]. Strahlenther Onkol 2003;179:682-9. (Pubitemid 37254662)
25. Wolff HA, Bosch J, Jung K et al. High-grade acute organ toxicity as positive prognostic factor in primary radio (chemo) therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 2010;186:262-8.
26. Yao H, Wang H, Zhang Z et al. Sulforaphane inhibited expression of hypoxiainducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Int J Cancer 2008;123:1255-61.
27. Yeh CT, Yen GC. Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 2005;26:2138-48.
28. Yu D, Sekine-Suzuki E, Xue L et al. Chemopreventive agent sulforaphane enhances radiosensitivity in human tumor cells. Int J Cancer 2009;125:1205-11.